Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-09-12

Clinical Trial Update: Thermotherapy + a Short Course of Miltefosine for the Treatment of Uncomplicated Cutaneous Leishmaniasis in the New World¨ [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating thermotherapy plus a short course of miltefosine for uncomplicated cutaneous leishmaniasis in the New World has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Miltefosine (miltefosine)

Snippet

Sponsor: Drugs for Neglected Diseases | Conditions: Cutaneous Leishmaniasis | Phase 2 | Status: COMPLETED